Literature DB >> 20871597

Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.

Daiki Miki1, Michiaki Kubo, Atsushi Takahashi, Kyong-Ah Yoon, Jeongseon Kim, Geon Kook Lee, Jae Ill Zo, Jin Soo Lee, Naoya Hosono, Takashi Morizono, Tatsuhiko Tsunoda, Naoyuki Kamatani, Kazuaki Chayama, Takashi Takahashi, Johji Inazawa, Yusuke Nakamura, Yataro Daigo.   

Abstract

Lung cancer is the most common cause of death from cancer worldwide, and its incidence is increasing in East Asian and Western countries. To identify genetic factors that modify the risk of lung adenocarcinoma, we conducted a genome-wide association study in a Japanese cohort, with replication in two independent studies in Japanese and Korean individuals, in a total of 2,098 lung adenocarcinoma cases and 11,048 controls. The combined analyses identified two susceptibility loci for lung adenocarcinoma: TERT (rs2736100, combined P = 2.91 × 10⁻¹¹), odds ratio (OR) = 1.27) and TP63 (rs10937405, combined P = 7.26 × 10⁻¹²), OR = 1.31). Fine mapping of the region containing TP63 showed that a SNP (rs4488809) in intron 1 of TP63 showed the most significant association. Our results suggest that genetic variation in TP63 may influence susceptibility to lung adenocarcinoma in East Asian populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871597     DOI: 10.1038/ng.667

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  33 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 2.  The BioBank Japan Project.

Authors:  Yusuke Nakamura
Journal:  Clin Adv Hematol Oncol       Date:  2007-09

3.  EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.

Authors:  Antonio Marchetti; Carla Martella; Lara Felicioni; Fabio Barassi; Simona Salvatore; Antonio Chella; Pier P Camplese; Teodorico Iarussi; Felice Mucilli; Andrea Mezzetti; Franco Cuccurullo; Rocco Sacco; Fiamma Buttitta
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

Review 4.  The roles of p63 in cancer.

Authors:  Elsa R Flores
Journal:  Cell Cycle       Date:  2007-02-03       Impact factor: 4.534

5.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

6.  Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Authors:  Masahiro Fukuoka; Seiji Yano; Giuseppe Giaccone; Tomohide Tamura; Kazuhiko Nakagawa; Jean-Yves Douillard; Yutaka Nishiwaki; Johan Vansteenkiste; Shinzoh Kudoh; Danny Rischin; Richard Eek; Takeshi Horai; Kazumasa Noda; Ichiro Takata; Egbert Smit; Steven Averbuch; Angela Macleod; Andrea Feyereislova; Rui-Ping Dong; José Baselga
Journal:  J Clin Oncol       Date:  2003-05-14       Impact factor: 44.544

7.  Projected mortality from lung cancer in South Korea, 1980-2004.

Authors:  S H Jee; I S Kim; I Suh; D Shin; L J Appel
Journal:  Int J Epidemiol       Date:  1998-06       Impact factor: 7.196

Review 8.  The changing epidemiology of lung cancer in Europe.

Authors:  Maryska L G Janssen-Heijnen; Jan-Willem W Coebergh
Journal:  Lung Cancer       Date:  2003-09       Impact factor: 5.705

9.  Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.

Authors:  A Petitjean; C Ruptier; V Tribollet; A Hautefeuille; F Chardon; C Cavard; A Puisieux; P Hainaut; C Caron de Fromentel
Journal:  Carcinogenesis       Date:  2007-11-28       Impact factor: 4.944

10.  Trends in lung cancer incidence by histological type in Osaka, Japan.

Authors:  Yasuhiro Toyoda; Tomio Nakayama; Akiko Ioka; Hideaki Tsukuma
Journal:  Jpn J Clin Oncol       Date:  2008-08-09       Impact factor: 3.019

View more
  93 in total

1.  Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Authors:  Krista A Zanetti; Zhaoming Wang; Melinda Aldrich; Christopher I Amos; William J Blot; Elise D Bowman; Laurie Burdette; Qiuyin Cai; Neil Caporaso; Charles C Chung; Elizabeth M Gillanders; Christopher A Haiman; Helen M Hansen; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Shengchao Li; Lorna Haughton McNeill; Bríd M Ryan; Ann G Schwartz; Jennette D Sison; Margaret R Spitz; Margaret Tucker; Angela S Wenzlaff; John K Wiencke; Lynne Wilkens; Margaret R Wrensch; Xifeng Wu; Wei Zheng; Weiyin Zhou; David Christiani; Julie R Palmer; Trevor M Penning; Alyssa G Rieber; Lynn Rosenberg; Edward A Ruiz-Narvaez; Li Su; Anil Vachani; Yongyue Wei; Alexander S Whitehead; Stephen J Chanock; Curtis C Harris
Journal:  Lung Cancer       Date:  2016-05-13       Impact factor: 5.705

Review 2.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

3.  A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits.

Authors:  Samsiddhi Bhattacharjee; Preetha Rajaraman; Kevin B Jacobs; William A Wheeler; Beatrice S Melin; Patricia Hartge; Meredith Yeager; Charles C Chung; Stephen J Chanock; Nilanjan Chatterjee
Journal:  Am J Hum Genet       Date:  2012-05-04       Impact factor: 11.025

4.  Integrating genetic and genomic information into effective cancer care in diverse populations.

Authors:  L Fashoyin-Aje; K Sanghavi; K Bjornard; J Bodurtha
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

5.  Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk.

Authors:  Bin Hu; Ying Huang; Rong-huan Yu; Hong-ju Mao; Chao Guan; Jing Zhao
Journal:  Tumour Biol       Date:  2013-11-20

6.  CRR9p polymorphism as a protective factor for lung cancer.

Authors:  Yang Chen; Zhiguo Yu; Bo Zhang; Zhengqi Chang; Hong Wang; Zhandi Liu
Journal:  Tumour Biol       Date:  2014-06-24

7.  Common genetic variants on 3q28 contribute to non-small cell lung cancer susceptibility: evidence from 10 case-control studies.

Authors:  Yu-xing Jin; Ge-ning Jiang; Hui Zheng; Liang Duan; Jia-an Ding
Journal:  Mol Genet Genomics       Date:  2014-10-25       Impact factor: 3.291

8.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.

Authors:  Zhibin Hu; Chen Wu; Yongyong Shi; Huan Guo; Xueying Zhao; Zhihua Yin; Lei Yang; Juncheng Dai; Lingmin Hu; Wen Tan; Zhiqiang Li; Qifei Deng; Jiucun Wang; Wei Wu; Guangfu Jin; Yue Jiang; Dianke Yu; Guoquan Zhou; Hongyan Chen; Peng Guan; Yijiang Chen; Yongqian Shu; Lin Xu; Xiangyang Liu; Li Liu; Ping Xu; Baohui Han; Chunxue Bai; Yuxia Zhao; Haibo Zhang; Ying Yan; Hongxia Ma; Jiaping Chen; Mingjie Chu; Feng Lu; Zhengdong Zhang; Feng Chen; Xinru Wang; Li Jin; Jiachun Lu; Baosen Zhou; Daru Lu; Tangchun Wu; Dongxin Lin; Hongbing Shen
Journal:  Nat Genet       Date:  2011-07-03       Impact factor: 38.330

Review 9.  TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.

Authors:  Hui-Min Wang; Xue-Yan Zhang; Bo Jin
Journal:  Genet Test Mol Biomarkers       Date:  2013-12

10.  Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population.

Authors:  Qun-Ying Hu; Tian-Bo Jin; Li Wang; Le Zhang; Tingting Geng; Guinian Liang; Long-Li Kang
Journal:  Tumour Biol       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.